Market Closed -
Nasdaq Stockholm
03:50:40 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
35.6
SEK
|
-0.84%
|
|
+0.28%
|
-25.37%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,775
|
2,065
|
2,442
|
966.5
|
1,220
|
910.3
|
-
|
-
|
Enterprise Value (EV)
1 |
1,742
|
2,028
|
2,444
|
935.9
|
1,170
|
831.2
|
798.6
|
742.5
|
P/E ratio
|
-70
x
|
-155
x
|
-83.6
x
|
-31
x
|
-434
x
|
45.6
x
|
22.2
x
|
14.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11.9
x
|
15
x
|
13.2
x
|
4.43
x
|
4.46
x
|
2.71
x
|
2.21
x
|
1.84
x
|
EV / Revenue
|
11.7
x
|
14.7
x
|
13.2
x
|
4.29
x
|
4.28
x
|
2.48
x
|
1.94
x
|
1.5
x
|
EV / EBITDA
|
-135
x
|
-495
x
|
978
x
|
-240
x
|
48.4
x
|
16.1
x
|
10.2
x
|
6.9
x
|
EV / FCF
|
-
|
390
x
|
-78.8
x
|
505
x
|
39.6
x
|
28.2
x
|
24.4
x
|
13.3
x
|
FCF Yield
|
-
|
0.26%
|
-1.27%
|
0.2%
|
2.52%
|
3.55%
|
4.09%
|
7.52%
|
Price to Book
|
14.1
x
|
12.6
x
|
17.8
x
|
5.94
x
|
7.67
x
|
5.03
x
|
4.09
x
|
3.22
x
|
Nbr of stocks (in thousands)
|
24,147
|
24,728
|
24,769
|
25,569
|
25,569
|
25,569
|
-
|
-
|
Reference price
2 |
73.50
|
83.50
|
98.60
|
37.80
|
47.70
|
35.60
|
35.60
|
35.60
|
Announcement Date
|
2/27/20
|
2/4/21
|
2/3/22
|
2/3/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
149.4
|
137.5
|
185.1
|
218
|
273.6
|
335.4
|
412.1
|
494.7
|
EBITDA
1 |
-12.9
|
-4.1
|
2.5
|
-3.9
|
24.2
|
51.75
|
78.38
|
107.5
|
EBIT
1 |
-24.48
|
-18.21
|
-19.72
|
-23.95
|
-0.679
|
24.85
|
50.25
|
77.93
|
Operating Margin
|
-16.38%
|
-13.25%
|
-10.65%
|
-10.99%
|
-0.25%
|
7.41%
|
12.2%
|
15.75%
|
Earnings before Tax (EBT)
1 |
-26.24
|
-18.59
|
-21.27
|
-24.04
|
-0.013
|
24.96
|
50.4
|
78.46
|
Net income
1 |
-20.6
|
-13.1
|
-29.2
|
-30.66
|
-2.817
|
20.25
|
40.94
|
63.45
|
Net margin
|
-13.79%
|
-9.53%
|
-15.78%
|
-14.07%
|
-1.03%
|
6.04%
|
9.93%
|
12.82%
|
EPS
2 |
-1.050
|
-0.5400
|
-1.180
|
-1.220
|
-0.1100
|
0.7803
|
1.607
|
2.492
|
Free Cash Flow
1 |
-
|
5.196
|
-31.03
|
1.854
|
29.53
|
29.5
|
32.67
|
55.8
|
FCF margin
|
-
|
3.78%
|
-16.76%
|
0.85%
|
10.79%
|
8.79%
|
7.93%
|
11.28%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
122.02%
|
57%
|
41.68%
|
51.89%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
145.67%
|
79.8%
|
87.95%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
2/4/21
|
2/3/22
|
2/3/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
38.67
|
67.7
|
53.08
|
45.11
|
51.1
|
68.66
|
64.96
|
74.31
|
63.9
|
70.43
|
78.25
|
82.75
|
81.25
|
91.65
|
EBITDA
1 |
-0.6
|
12
|
-1.3
|
-12.2
|
-1.9
|
11.5
|
7.3
|
10.7
|
4
|
2.3
|
8.728
|
10.9
|
10.96
|
20.49
|
EBIT
1 |
-5.788
|
4.019
|
-6.082
|
-17.22
|
-7.255
|
6.602
|
0.103
|
4.822
|
-2.043
|
-3.561
|
1.978
|
4.148
|
4.213
|
13.24
|
Operating Margin
|
-14.97%
|
5.94%
|
-11.46%
|
-38.17%
|
-14.2%
|
9.62%
|
0.16%
|
6.49%
|
-3.2%
|
-5.06%
|
2.53%
|
5.01%
|
5.19%
|
14.45%
|
Earnings before Tax (EBT)
1 |
-6.521
|
3.075
|
-6.935
|
-16.75
|
-7.37
|
7.018
|
-0.632
|
4.771
|
-1.696
|
-2.455
|
2.103
|
6.474
|
6.624
|
12.69
|
Net income
1 |
-7.231
|
-4.2
|
-7.425
|
-17.64
|
-7.746
|
2.143
|
-1.483
|
1.473
|
0.016
|
-2.823
|
1.82
|
3.525
|
3.583
|
10.45
|
Net margin
|
-18.7%
|
-6.2%
|
-13.99%
|
-39.1%
|
-15.16%
|
3.12%
|
-2.28%
|
1.98%
|
0.03%
|
-4.01%
|
2.33%
|
4.26%
|
4.41%
|
11.4%
|
EPS
2 |
-0.2900
|
-0.1700
|
-0.3000
|
-0.7100
|
-0.3000
|
0.0800
|
-0.0600
|
0.0600
|
-
|
-0.1100
|
0.0642
|
0.1975
|
0.2021
|
0.3871
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/28/21
|
2/3/22
|
4/27/22
|
7/21/22
|
10/26/22
|
2/3/23
|
4/27/23
|
7/20/23
|
10/26/23
|
2/15/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
2.01
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
32.6
|
37.2
|
-
|
30.6
|
49.6
|
79.1
|
112
|
168
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.8028
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
5.2
|
-31
|
1.85
|
29.5
|
29.5
|
32.7
|
55.8
|
ROE (net income / shareholders' equity)
|
-
|
-9.09%
|
-19.5%
|
-20.5%
|
-1.75%
|
12%
|
20.6%
|
25.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
5.200
|
6.600
|
5.530
|
6.360
|
6.220
|
7.080
|
8.690
|
11.00
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
25.3
|
25.9
|
13.1
|
6.99
|
14.9
|
17.3
|
19.3
|
Capex / Sales
|
-
|
18.43%
|
13.99%
|
5.99%
|
2.55%
|
4.44%
|
4.2%
|
3.89%
|
Announcement Date
|
2/27/20
|
2/4/21
|
2/3/22
|
2/3/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
35.6
SEK Average target price
55.33
SEK Spread / Average Target +55.43% Consensus |
1st Jan change
|
Capi.
|
---|
| -25.37% | 82.87M | | +73.09% | 12.38B | | -18.39% | 7.61B | | +14.33% | 7.11B | | +4.77% | 5.83B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -19.09% | 4.02B | | -35.92% | 2.16B | | +1.24% | 2.01B |
Medical Equipment
|